Log In
Print this Print this

Emulsified Influenza HA Vaccine

Also known as: Cell culture-based pandemic influenza vaccine

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionCell culture-based pandemic influenza vaccine developed using EB66 cell line
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Cellular vaccine
Latest Stage of DevelopmentApproved
Standard IndicationInfluenza virus
Indication DetailsVaccinate against pandemic influenza virus infection
Regulatory Designation Japan - Orphan Drug (Vaccinate against pandemic influenza virus infection);
Japan - Standard Review (Vaccinate against pandemic influenza virus infection)
Partner Kaketsuken

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today